Estrogen-replacement therapy

Effects on retrobulbar hemodynamics

Mira Harris-Yitzhak, Alon Harris, Zion Ben-Refael, Drora Zarfati, Hanna J. Garzozi, Bruce J. Martin

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

PURPOSE: Estrogen-replacement therapy causes vasodilation and increased blood flow in major peripheral arteries. We examined the role that estrogen may play in enhancing perfusion within the watersheds of several major and minor retrobulbar arteries. METHODS: Postmenopausal women receiving estrogen-replacement therapy (n = 16) were compared with both age-matched women not receiving estrogen (n = 16) and with young women (n = 20). Studies involved color Doppler imaging analysis of flow velocities measured in the ophthalmic, central retinal, and nasal and temporal posterior ciliary arteries. RESULTS: In the ophthalmic artery, young women and postmenopausal women receiving estrogen exhibited reduced resistance indexes as compared with postmenopausal women not receiving estrogen (each P <.001). In contrast, flow velocities in the central retinal artery were similar among the three groups of women. In the posterior ciliary arteries, a different pattern emerged: young women, as compared with either group of postmenopausal women, showed greater peak systolic and end-diastolic velocities at similar resistance index (each P <.05). CONCLUSIONS: Estrogen-replacement therapy in postmenopausal women apparently helps reduce vascular resistance distal to the ophthalmic artery to levels matching those of young women. However, estrogen replacement has little impact on flow velocities in the posterior ciliary arteries. In those vessels, aging per se may reduce perfusion, potentially contributing to the age-dependent risk of major eye diseases, such as glaucoma and age-related macular degeneration. Copyright (C) 2000 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)623-628
Number of pages6
JournalAmerican Journal of Ophthalmology
Volume129
Issue number5
DOIs
StatePublished - May 2000
Externally publishedYes

Fingerprint

Estrogen Replacement Therapy
Hemodynamics
Ciliary Arteries
Estrogens
Ophthalmic Artery
Arteries
Perfusion
Retinal Artery
Eye Diseases
Macular Degeneration
Nose
Vasodilation
Vascular Resistance
Glaucoma
Color

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Harris-Yitzhak, M., Harris, A., Ben-Refael, Z., Zarfati, D., Garzozi, H. J., & Martin, B. J. (2000). Estrogen-replacement therapy: Effects on retrobulbar hemodynamics. American Journal of Ophthalmology, 129(5), 623-628. https://doi.org/10.1016/S0002-9394(99)00468-7

Estrogen-replacement therapy : Effects on retrobulbar hemodynamics. / Harris-Yitzhak, Mira; Harris, Alon; Ben-Refael, Zion; Zarfati, Drora; Garzozi, Hanna J.; Martin, Bruce J.

In: American Journal of Ophthalmology, Vol. 129, No. 5, 05.2000, p. 623-628.

Research output: Contribution to journalArticle

Harris-Yitzhak, M, Harris, A, Ben-Refael, Z, Zarfati, D, Garzozi, HJ & Martin, BJ 2000, 'Estrogen-replacement therapy: Effects on retrobulbar hemodynamics', American Journal of Ophthalmology, vol. 129, no. 5, pp. 623-628. https://doi.org/10.1016/S0002-9394(99)00468-7
Harris-Yitzhak, Mira ; Harris, Alon ; Ben-Refael, Zion ; Zarfati, Drora ; Garzozi, Hanna J. ; Martin, Bruce J. / Estrogen-replacement therapy : Effects on retrobulbar hemodynamics. In: American Journal of Ophthalmology. 2000 ; Vol. 129, No. 5. pp. 623-628.
@article{3ad17ee7e0d34464bd53a8e32988c59e,
title = "Estrogen-replacement therapy: Effects on retrobulbar hemodynamics",
abstract = "PURPOSE: Estrogen-replacement therapy causes vasodilation and increased blood flow in major peripheral arteries. We examined the role that estrogen may play in enhancing perfusion within the watersheds of several major and minor retrobulbar arteries. METHODS: Postmenopausal women receiving estrogen-replacement therapy (n = 16) were compared with both age-matched women not receiving estrogen (n = 16) and with young women (n = 20). Studies involved color Doppler imaging analysis of flow velocities measured in the ophthalmic, central retinal, and nasal and temporal posterior ciliary arteries. RESULTS: In the ophthalmic artery, young women and postmenopausal women receiving estrogen exhibited reduced resistance indexes as compared with postmenopausal women not receiving estrogen (each P <.001). In contrast, flow velocities in the central retinal artery were similar among the three groups of women. In the posterior ciliary arteries, a different pattern emerged: young women, as compared with either group of postmenopausal women, showed greater peak systolic and end-diastolic velocities at similar resistance index (each P <.05). CONCLUSIONS: Estrogen-replacement therapy in postmenopausal women apparently helps reduce vascular resistance distal to the ophthalmic artery to levels matching those of young women. However, estrogen replacement has little impact on flow velocities in the posterior ciliary arteries. In those vessels, aging per se may reduce perfusion, potentially contributing to the age-dependent risk of major eye diseases, such as glaucoma and age-related macular degeneration. Copyright (C) 2000 Elsevier Science Inc.",
author = "Mira Harris-Yitzhak and Alon Harris and Zion Ben-Refael and Drora Zarfati and Garzozi, {Hanna J.} and Martin, {Bruce J.}",
year = "2000",
month = "5",
doi = "10.1016/S0002-9394(99)00468-7",
language = "English (US)",
volume = "129",
pages = "623--628",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Estrogen-replacement therapy

T2 - Effects on retrobulbar hemodynamics

AU - Harris-Yitzhak, Mira

AU - Harris, Alon

AU - Ben-Refael, Zion

AU - Zarfati, Drora

AU - Garzozi, Hanna J.

AU - Martin, Bruce J.

PY - 2000/5

Y1 - 2000/5

N2 - PURPOSE: Estrogen-replacement therapy causes vasodilation and increased blood flow in major peripheral arteries. We examined the role that estrogen may play in enhancing perfusion within the watersheds of several major and minor retrobulbar arteries. METHODS: Postmenopausal women receiving estrogen-replacement therapy (n = 16) were compared with both age-matched women not receiving estrogen (n = 16) and with young women (n = 20). Studies involved color Doppler imaging analysis of flow velocities measured in the ophthalmic, central retinal, and nasal and temporal posterior ciliary arteries. RESULTS: In the ophthalmic artery, young women and postmenopausal women receiving estrogen exhibited reduced resistance indexes as compared with postmenopausal women not receiving estrogen (each P <.001). In contrast, flow velocities in the central retinal artery were similar among the three groups of women. In the posterior ciliary arteries, a different pattern emerged: young women, as compared with either group of postmenopausal women, showed greater peak systolic and end-diastolic velocities at similar resistance index (each P <.05). CONCLUSIONS: Estrogen-replacement therapy in postmenopausal women apparently helps reduce vascular resistance distal to the ophthalmic artery to levels matching those of young women. However, estrogen replacement has little impact on flow velocities in the posterior ciliary arteries. In those vessels, aging per se may reduce perfusion, potentially contributing to the age-dependent risk of major eye diseases, such as glaucoma and age-related macular degeneration. Copyright (C) 2000 Elsevier Science Inc.

AB - PURPOSE: Estrogen-replacement therapy causes vasodilation and increased blood flow in major peripheral arteries. We examined the role that estrogen may play in enhancing perfusion within the watersheds of several major and minor retrobulbar arteries. METHODS: Postmenopausal women receiving estrogen-replacement therapy (n = 16) were compared with both age-matched women not receiving estrogen (n = 16) and with young women (n = 20). Studies involved color Doppler imaging analysis of flow velocities measured in the ophthalmic, central retinal, and nasal and temporal posterior ciliary arteries. RESULTS: In the ophthalmic artery, young women and postmenopausal women receiving estrogen exhibited reduced resistance indexes as compared with postmenopausal women not receiving estrogen (each P <.001). In contrast, flow velocities in the central retinal artery were similar among the three groups of women. In the posterior ciliary arteries, a different pattern emerged: young women, as compared with either group of postmenopausal women, showed greater peak systolic and end-diastolic velocities at similar resistance index (each P <.05). CONCLUSIONS: Estrogen-replacement therapy in postmenopausal women apparently helps reduce vascular resistance distal to the ophthalmic artery to levels matching those of young women. However, estrogen replacement has little impact on flow velocities in the posterior ciliary arteries. In those vessels, aging per se may reduce perfusion, potentially contributing to the age-dependent risk of major eye diseases, such as glaucoma and age-related macular degeneration. Copyright (C) 2000 Elsevier Science Inc.

UR - http://www.scopus.com/inward/record.url?scp=0034112207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034112207&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(99)00468-7

DO - 10.1016/S0002-9394(99)00468-7

M3 - Article

VL - 129

SP - 623

EP - 628

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 5

ER -